• 1
    Di Stefano F, Siriruttanapruk S, McCoach JS, Burge PS. Occupational asthma due to glutaraldehyde. Monaldi Arch Chest Dis 1998;53:5055.
  • 2
    Gannon PFG, Bright P, Campbell M, et al. Occupational asthma due to glutaraldehyde and formaldehyde in endoscopy and x-ray departments. Thorax 1995;50:156159.
  • 3
    Stenton SC, Beach JR, Dennis JH, et al. Glutaraldehyde, asthma and work – a cautionary tale. Occup Med 1994;44:9598.
  • 4
    Curran AD, Burge PS, Wiley K. Clinical and immunologic evaluation of workers exposed to glutaraldehyde. Allergy 1996;51:826832.
  • 5
    Corrada OJ, Osman J, Davies JR. Asthma and rhinitis after exposure to glutaraldehyde in endoscopy units. Hum Toxicol 1986;5:325327.
  • 6
    Hauser R, Garcia-Glossas M, Kelsey KT, Christiani DC. Variability of nasal lavage polymorphonuclear leukocyte counts in unexposed subjects: its potential utility for epidemiology. Arch Environ Health 1994;49:267272.
  • 7
    NIOSH Manual of Analytical Methods. Glutaraldehyde. Method:2531, Issued:5/15/89.
  • 8
    Greiff L, Pipkorn U, Alkner U, et al. The “nasal pool” device applies controlled concentrations of solution on human nasal airway mucosa and samples its surface exudations and secretions. Clin Exp Allergy 1990;20:253259.
  • 9
    Pałczyński C, Walusiak J, Ruta U, Górski P. Nasal provocation test in the diagnosis of natural rubber latex allergy. Allergy 2000;55:3441.
  • 10
    Wihl JA. Methodological aspects of nasal allergen challenge based on a tree pollen immunotherapy study. Allergy 1986;41:357364.
  • 11
    Cockroft DW. Bronchial reactivity to histamine: a method and clinical survey. Clin Allergy 1977;7:503512.
  • 12
    Health and Safety Executives. Occupational exposure limits: criteria document summaries. London: HSE Books, 1993.
  • 13
    Glutardialdehyd. Toxikologischarbeitsmedizinische Begründung von MAK-Werten. München:1994.
  • 14
    Malo JR, Lemiere C, Desjardins A, Cartier A. Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J 1997;10:15131515.
  • 15
    Christiani DC & Malo JL. Upper airways involvement. In: BernsteinIL, Chan YeungM, MaloJL, BernsteinDI, editors. Asthma in the workplace. New York: Marcel Dekker, 1999:331339.
  • 16
    Górski P, Krakowiak A, Pazdrak K, et al. Nasal challenge test in the diagnosis of allergic respiratory diseases in subjects occupationally exposed to high molecular weight allergen (flour). Occup Med 1998;48:9197.
  • 17
    Raulf-Heimsoth M, Wirtz C, Papenfuss F, Baur X. Nasal lavage mediator profile and cellular composition of nasal brushing material during latex challenge test. Clin Exp Allergy 2000;30:110121.DOI: 10.1046/j.1365-2222.2000.00690.x
  • 18
    Melillo G, Bonini S, Cocco G, et al. Provocation tests with allergens. Allergy 1997;52 Suppl 35:535.
  • 19
    Dearman RJ, Basketter DA, Evans P, Kimber A. Comparison of cytokine secretion profiles provoked in mice by glutaraldehyde and formaldehyde. Clin Exp Allergy 1999;29:124132.DOI: 10.1046/j.1365-2222.1999.00437.x
  • 20
    Bentley AM, Maestrelli P, Saetta M, et al. Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol 1992;89:821829.
  • 21
    Maestrelli P, Occari P, Turato G, et al. Expression of interleukin (IL)-4 and IL-5 in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy 1997;27:12921298.
  • 22
    Uliński S, Pałczyński C, Górski P. Occupational rhinitis and bronchial asthma due to morphine: evidence from inhalation and nasal challenges. Allergy 1996;51:914918.
  • 23
    Krakowiak A, Ruta U, Gruchała J, Górski P. Cellular and biochemical findings in nasal and bronchoalveolar lavage of patients with occupational asthma due to diisocyanates. Eur Respir J 1999, 14, s30.[Abstract].
  • 24
    Wang DY, Clement P, Smitz J, et al. Quantification of eosinophil cationic protein and eosinophils in nasal secretions of allergen-induced nasal inflammation. Allergol Immunopathol (Madr) 1994;22:2327.
  • 25
    Castells M & Schwartz LB. Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response. J Allergy Clin Iimmunol 1988;82:348355.